Skip to main content
EXO-HEP • RESEARCH USE ONLY

Hepatic Exosomes

Derived from stem cells differentiated toward hepatic lineage (human liver stem cell / HLSC–related), carrying liver-specific miRNAs, mRNAs, and proteins.

Product image for Hepatic Exosomes
HLSC-lineage EVs
LIVER-SPECIFIC CARGO
— Differentiated hepatic stem cell exosomes carrying organ-specific miRNAs, mRNAs, and proteins that mirror native hepatocyte/cholangiocyte signaling.
Anti-fibrotic · pro-survival
TARGETED REPAIR
— Delivers anti-inflammatory, anti-fibrotic, and pro-survival RNAs aimed at resolving damaged parenchyma without live-cell transplant risk.
ALF · cirrhosis · NASH
INDICATION MAP
— Covers acute failure, chronic injury, drug/toxin insults, steatohepatitis, genetic iron/copper overloads, autoimmune cholangiopathies, and HCC adjacency research.
ROUTES, FORMATS & APPLICATIONS
Routes
IVIntravenousIMIntramuscular
Quantities
400 Billion Exosomes1ml
Potential Applications

These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.

  • Acute Liver Failure (ALF)
  • Chronic Liver Injury
  • Drug-Induced Liver Injury
  • Cirrhosis (fibrosis reversal)
  • Post-hepatectomy liver regeneration
  • Fatty Liver Disease
  • Hemochromatosis
  • Wilson Disease
  • Non-alcoholic Steatohepatitis (NASH)
  • Hepatocellular Carcinoma (HCC)
  • Autoimmune hepatitis
  • Primary biliary cholangitis
  • Primary sclerosing cholangitis
  • Ischemia-Reperfusion Liver Injury
  • Chemotherapy-Induced Liver Damage
  • Liver adhesion formation (post-surgery)
  • Peritoneal adhesion reduction post-liver surgery

Compliance · Exosomes

cGMP manufacturing & cryopreservation

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY
Viability & cryopreservation

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More

Keep browsing our product lineup